Abbott to acquire Exact Sciences for $21 billion

Abbott announced a definitive agreement to acquire Exact Sciences for $105 per share, total equity value of approximately $21 billion, adding cancer screening and precision oncology diagnostics.

“This acquisition adds a new growth vertical to Abbott’s already high single-digit growth profile.”exactsciences.com

• 1 source
• exactsciences.comAbbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precisionExact SciencesNov 20, 2025

Summarized from public sources; check the original articles before acting on it.